Mecure Industries PLC (NGX:MECURE)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
79.85
0.00 (0.00%)
At close: May 12, 2026
Market Cap319.40B +609.8%
Revenue (ttm)84.55B +65.0%
Net Income7.23B +220.7%
EPS1.82 +224.4%
Shares Out4.00B
PE Ratio43.82
Forward PEn/a
Dividend0.32 (0.40%)
Ex-Dividend DateApr 24, 2026
Volume743,264
Average Volume1,248,583
Openn/a
Previous Close79.85
Day's Rangen/a
52-Week Range11.10 - 104.00
Beta0.94
RSI77.54
Earnings DateApr 28, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company engages in distributing multivitamins products. It also offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. In addition, the company provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Further, it is involved in the contract manufacturing services. It sells its products throu... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 195
Stock Exchange Nigerian Stock Exchange
Ticker Symbol MECURE
Full Company Profile

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.

Financial Statements